The DOI matches its Crossref record; 272 of the 272 references it cites were found in a registry or an index.
Evidence-based guidelines for the pharmacological treatment of anxiety disorders: recommendations from the British Association for Psychopharmacology
Open accessAbstract
These British Association for Psychopharmacology guidelines cover the range and aims of treatment for anxiety disorders. They are based explicitly on the available evidence and are presented as recommendations to aid clinical decision making in primary and secondary medical care. They may also serve as a source of information for patients and their carers. The recommendations are presented together with a more detailed review of the available evidence. A consensus meeting involving experts in anxiety disorders reviewed the main subject areas and considered the strength of evidence and its clinical implications. The guidelines were constructed after extensive feedback from participants and interested parties. The strength of supporting evidence for recommendations was rated. The guidelines cover the diagnosis of anxiety disorders and key steps in clinical management, including acute treatment, relapse prevention and approaches for patients who do not respond to first-line treatments.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“This is in line with the clinical observation that specific phobias respond less well to treatments such as citalopram than other pathological anxiety states (Baldwin et al, 2005) and with preclinical evidence in rodents showing that the serotonergic system may not be critical for the expression of phasic fear-potentiated startle (Davis et al, 1988).”
From Phasic vs Sustained Fear in Rats and Humans: Role of the Extended Amygdala in Fear vs Anxiety (2010) · cites this paper as Baldwin et al, 2005
Citations
Cites
1 retracted
Antidepressants for generalised anxiety disorder (GAD)
Kapczinski, F., dos Santos Souza, J. J., Batista Miralha da Cunha, A. A., & Schmitt, R. R. (2003) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003592 · Cited by 162
RetractedDiagnostic and Statistical Manual of Mental Disorders
Williams, J. B. W., & First, M. (2013) · Encyclopedia of Social Work · doi:10.1093/acrefore/9780199975839.013.104 · Cited by 109,519
The Hospital Anxiety and Depression Scale
Zigmond, A. S., & Snaith, R. P. (1983) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.1983.tb09716.x · Cited by 47,139
Kessler, R. C. (1994) · Archives of General Psychiatry · doi:10.1001/archpsyc.1994.03950010008002 · Cited by 12,370
Posttraumatic Stress Disorder in the National Comorbidity Survey
Kessler, R. C. (1995) · Archives of General Psychiatry · doi:10.1001/archpsyc.1995.03950240066012 · Cited by 10,379
The validity of the Hospital Anxiety and Depression Scale
Bjelland, I., Dahl, A. A., Haug, T. T., & Neckelmann, D. (2002) · Journal of Psychosomatic Research · doi:10.1016/s0022-3999(01)00296-3 · Cited by 9,779
Prevalence and development of psychiatric disorders in childhood and adolescence
Costello, E. J., Mustillo, S., Erkanli, A., Keeler, G., & Angold, A. (2003) · Archives of General Psychiatry · doi:10.1001/archpsyc.60.8.837 · Cited by 4,035
The National Institute for Clinical Excellence
(2001) · Nursing Management · doi:10.7748/nm.8.2.39.s15 · Cited by 3,876
Size and burden of mental disorders in Europe—a critical review and appraisal of 27 studies
Wittchen, H.-U., & Jacobi, F. (2005) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2005.04.012 · Cited by 1,503
The economic burden of anxiety disorders in the 1990s
Greenberg, P. E., Sisitsky, T., Kessler, R. C., Finkelstein, S. N., Berndt, E. R., Davidson, J. R. T., Ballenger, J. C., & Fyer, A. J. (1999) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v60n0702 · Cited by 1,242 · cited 1×
“Anxiety disorders are associated with a substantial economic burden, both for the health system and (especially) for the wider society in terms of productivity losses (I) (Souetre et al., 1994; Salvador-Carulla et al., 1995; Rice and Miller, 1998; Greenberg et al., 1999; Andlin-Sobocki & Wittchen, 2005), but there hav…”
BackgroundSelf-citation
Research works printed but not linked: 41
- Allgulander C, ADAA meeting
- 10.1177/026988110001400101 · DOI · Paper page
- Baldwin D S, 1998, J Clin Psychiatry, 59, S39
- Ballenger J C, 1998, J Clin Psychiatry, 59, 47
- Ballenger J C, 1998, J Clin Psychiatry, 59, 54
- Ballenger J C, 2001, J Clin Psychiatry, 62, 53
- Ballenger J C, 2004, J Clin Psychiatry, 65, 55
- Bielski R J, 42nd Annual Meeting of the American College of Neuropsychopharmacology
- Bower P, 2001, Br J Gen Pract, 51, 838
- Committee on Safety of Medicines, 2004, Safety of selective serotonin reuptake inhibitor antidepressants
- Davidson J R, American College of Neuropsychopharmacology
- Den Boer J A, 1998, J Clin Psychiatry, 59, 30
- Dowell A C, 1990, Br J Gen Pract, 40, 27
- Durham R C, Long-term outcome of cognitive behavior therapy clinical trials in central Scotland
- Friedman M J, 2000, Effective Treatments for PTSD: Practice Guidelines from the International Society for Stress Studies, 84
- Gelpin E, 1996, J Clin Psychiatry, 57, 390
- Goldberg D, 1987, J R Coll Gen Pract, 37, 15
- Jorm A F, 2004, Med J Aust, 181, S29
- 10.1037/0022-006X.62.4.865 · DOI · Paper page
- 10.1002/(SICI)1520-6394(1999)10:3<89::AID-DA1>3.0.CO;2-5 · doi:10.1002/(sici)1520-6394(1999)10:3<89::aid-da1>3.0.co;2-5
- Meibach R C, 1987, J Clin Psychiatry, 84, 355
- Mendels J, 1986, J Clin Psychiatry, 47, 170
- National Institute for Clinical Excellence, 2004, Depression. Management of depression in primary and secondary care
- National Institute for Clinical Excellence, 2005, Post-traumatic stress disorder. The management of PTSD in adults and children in primary and secondary care
- Parkerson G R Jr, 1997, Fam Med, 29, 177
- Pollack M H, American College of Neuropsychopharmacology
- Pollack M H, 1994, J Clin Psychiatry, 55, 200
- Power K G, 1990, Br J Gen Pract, 40, 289
- 10.1034/j.1600-0447.2001.00263.x · DOI · Paper page
- Rasmussen S A, 1990, J Clin Psychiatry, 51, 10
- Royal College of Psychiatrists, 2005, Benzodiazepines: risks, benefits or dependence. A re-evaluation
- Sasson Y, 1997, J Clin Psychiatry, 58, 7
- Schatzberg A F, 1997, J Clin Psychiatry, 58, 5
- Stein D J, 2004, Cochrane Library
- Tollefson G D, 1994, J Clin Psychiatry, 55, 69
- 10.1002/(SICI)1099-0879(199809)5:3<126::AID-CPP153>3.0.CO;2-H · doi:10.1002/(sici)1099-0879(199809)5:3<126::aid-cpp153>3.0.co;2-h
- Weissman M M, 1994, J Clin Psychiatry, 55, 5
- Wheadon D, Annual Meeting of the American College of Neuro psychopharmacology
- Wittchen H U, 2002, J Clin Psychiatry, 63, 24
- World Health Organization, 1992, The ICD-10 classification of mental and behavioural disorders: clinical descriptions and diagnostic guidelines
- World Health Organization, 2004, WHO Guide to Mental and Neurological Health in Primary Care
Cited by
Phasic vs Sustained Fear in Rats and Humans: Role of the Extended Amygdala in Fear vs Anxiety
Davis, M., Walker, D. L., Miles, L., & Grillon, C. (2010) · Neuropsychopharmacology · doi:10.1038/npp.2009.109 · Cited by 1,513
Comorbidity of anxiety and depression in children and adolescents: 20 years after
Cummings, C. M., Caporino, N. E., & Kendall, P. C. (2014) · Psychological Bulletin · doi:10.1037/a0034733 · Cited by 1,028
Anderson, I., Ferrier, I., Baldwin, R., Cowen, P., Howard, L., Lewis, G., Matthews, K., McAllister-Williams, R., Peveler, R., Scott, J., et al. (2008) · Journal of Psychopharmacology · doi:10.1177/0269881107088441 · Cited by 908
Self-citationBandelow, B., Zohar, J., Hollander, E., Kasper, S., Möller, H.-J., WFSBP TASK FORCE ON TREATMENT GUIDE, Bandelow, B., Zohar, J., Hollander, E., Kasper, S., et al. (2008) · The World Journal of Biological Psychiatry · doi:10.1080/15622970802465807 · Cited by 854
Self-citationBenzodiazepine Use in the United States
Olfson, M., King, M., & Schoenbaum, M. (2015) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2014.1763 · Cited by 786
Metadata
- Authors
- Baldwin, D. S., Anderson, I. M., Nutt, D. J., Bandelow, B., Bond, A., Davidson, J. R. T., den Boer, J. A., Fineberg, N. A., Knapp, M., Scott, J., & Wittchen, H. U.
- Affiliations
- University of Southampton (GB)
- University of Manchester (GB)
- University of Bristol (GB)
- University of Göttingen (DE)
- King's College London (GB)
- Duke Medical Center (US)
- School of Behavioral and Cognitive Neurosciences, University Medical Center Groningen, Groningen, the Netherlands
- University of Hertfordshire (GB)
- Technical University of Dresden and Max Planck Institute of Psychiatry, Munich, Germany
- Corresponding author
- Baldwin, David S.
- ORCID
- Venue
- Journal of Psychopharmacology
- Publisher
- SAGE Publications
- Published
- 2005-11
- Volume
- 19
- Issue
- 6
- Pages
- 567-596
- ISSN
- 0269-8811 (ISSN-L)
- 1461-7285
- OpenAlex
- W2151852296
- Cited by
- 617
- References
- 272
- Citations by year
- 2026: 7 · 2025: 8 · 2024: 13 · 2023: 6 · 2022: 9 · 2021: 21 · 2020: 22 · 2019: 22 · 2018: 26 · 2017: 24 · 2016: 22 · 2015: 29 · 2014: 53 · 2013: 47 · 2012: 53
- FWCI
- 45.54
- Type
- journal article
- Language
- en
- Open access
- green
- tud.qucosa.de
- Licence
- other-oa
- journals.sagepub.com/page/policies/text-and-data-mining-license (tdm)
- Locations
- Journal of Psychopharmacology (publishedVersion)
- PubMed (publishedVersion)
- University of Groningen research database (University of Groningen / Centre for Information Technology) (publishedVersion)
- Max Planck Institute for Plasma Physics (submittedVersion)
- ePrints Soton (University of Southampton) (submittedVersion)
- Research Portal (King's College London) (submittedVersion)
- Qucosa (Saxon State and University Library Dresden) (submittedVersion, other-oa)
- University of Groningen research database (University of Groningen / Centre for Information Technology) (submittedVersion)
- Topics
- Social Sciences › Psychology › Experimental and Cognitive Psychology › Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes
- Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
- Health Sciences › Medicine › Psychiatry and Mental health › Mental Health Treatment and Access
- Keywords
- anxiety disorders, pharmacotherapy, psychopharmacology, treatment guidelines, evidence-based recommendations, acute treatment, relapse prevention, treatment-resistant anxiety, clinical decision-making
- MeSH terms
- Adolescent, Adult, Aged, Antidepressive Agents, Anxiety Disorders, Behavior Therapy, Breast Feeding, Child, Preschool, Combined Modality Therapy, Female, Humans, Male, Middle Aged, Pregnancy, Psychotropic Drugs, Anti-Anxiety Agents, Treatment Outcome, Evidence-Based Medicine
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Evidence-based guidelines for the pharmacological treatment of anxiety disorders: recommendations from the British Association for Psychopharmacology. https://app.cochat.ai/papers/10.1177/0269881105059253
- The paper
- Baldwin, D. S., Anderson, I. M., Nutt, D. J., Bandelow, B., Bond, A., Davidson, J. R. T., den Boer, J. A., Fineberg, N. A., Knapp, M., Scott, J., & Wittchen, H. U. (2005). Evidence-based guidelines for the pharmacological treatment of anxiety disorders: recommendations from the British Association for Psychopharmacology. Journal of Psychopharmacology. https://doi.org/10.1177/0269881105059253
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.